+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Efficacy of desmopressin and enuresis alarm as first and second line treatment for primary monosymptomatic nocturnal enuresis: prospective randomized crossover study



Efficacy of desmopressin and enuresis alarm as first and second line treatment for primary monosymptomatic nocturnal enuresis: prospective randomized crossover study



Journal of Urology 184(6): 2521-2526



We compared the efficacy of desmopressin and enuresis alarm as first and second line treatment options for monosymptomatic nocturnal enuresis. A total of 104 children with monosymptomatic nocturnal enuresis were randomly assigned to either desmopressin (54) or enuresis alarm (50) as first line treatment. Following 12 weeks of first line treatment children with a full response were evaluated for relapse 12 weeks after withdrawal of treatment. Children with partial or no response were switched to the alternative treatment and then evaluated after 12 weeks of crossover treatment. Relapse was defined as more than 1 episode of bedwetting monthly. Following first line treatment 77.8% of the desmopressin group and 82% of the enuresis alarm group achieved a successful result, including full response in 37% and 50% of the groups, respectively (p=0.433). Of the children with a full response 50% in the desmopressin group and 12% in the enuresis alarm group experienced a relapse when treatment stopped (p=0.005). Following second line crossover treatment 71.4% of the enuresis alarm-desmopressin group and 67.8% of the desmopressin-enuresis alarm group achieved a successful result, including full response in 47.6% and 45.2% of the groups, respectively (p=0.961). There was no difference between desmopressin and enuresis alarm during treatment for achieving dryness, but the chance of relapse after treatment stopped was higher following desmopressin. Switching to the alternative treatment following partial or no response provided an additional benefit.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052901033

Download citation: RISBibTeXText

PMID: 20961574

DOI: 10.1016/j.juro.2010.08.041


Related references

Efficacy of an enuresis alarm, desmopressin, and combination therapy in the treatment of saudi children with primary monosymptomatic nocturnal enuresis. Korean Journal of Urology 54(11): 783-790, 2013

Efficacy and safety during long-term treatment of primary monosymptomatic nocturnal enuresis with desmopressin. Swedish Enuresis Trial Group. Acta Paediatrica 88(11): 1274-1278, 1999

Enuresis alarm treatment as a second line to pharmacotherapy in children with monosymptomatic nocturnal enuresis. Journal of Urology 171(6 Pt 2): 2615-2617, 2004

Desmopressin alone versus desmopressin and an anticholinergic in the first-line treatment of primary monosymptomatic nocturnal enuresis: a multicenter study. Pediatric Nephrology 29(7): 1195-1200, 2015

Combination of the enuresis alarm and desmopressin: second line treatment for nocturnal enuresis. Journal of Urology 179(3): 1128-1131, 2008

Efficacy of desmopressin combined with alarm therapy for monosymptomatic nocturnal enuresis. Journal of Urology 166(6): 2456-2458, 2001

Comparison of desmopressin, alarm, desmopressin plus alarm, and desmopressin plus anticholinergic agents in the management of paediatric monosymptomatic nocturnal enuresis: a network meta-analysis. Bju International 2018, 2018

Long-term treatment with desmopressin in children with primary monosymptomatic nocturnal enuresis: an open multicentre study. Swedish Enuresis Trial (SWEET) Group. British Journal of Urology 82(5): 704-709, 1998

Efficacy and safety during long-term treatment of primary monosymptomatic nocturnal enuresis with desmopressin. Acta Paediatrica 88(11): 1274-1278, 1999

Comparison of long-term efficacy of desmopressin lyophilisate and enuretic alarm for monosymptomatic enuresis and assessment of predictive factors for success: a randomized prospective trial. Journal of Urology 193(2): 655-661, 2015

The efficacy of an enuresis alarm in monosymptomatic nocturnal enuresis. Singapore Medical Journal 50(9): 879-880, 2009

Role of Urodynamic Study in Nocturnal Enuresis: Urodynamic Findings and Treatment Outcome Correlation in Children with Pharmacotherapy-resistant Monosymptomatic Nocturnal Enuresis or Severe Non-monosymptomatic Nocturnal Enuresis. Lower Urinary Tract Symptoms 6(2): 88-93, 2014

The efficacy of the addition of short-term desmopressin to alarm therapy in the treatment of primary nocturnal enuresis. International Urology and Nephrology 40(3): 583-586, 2008

Combined therapy of enuresis alarm and desmopressin in the treatment of nocturnal enuresis. European Journal of Pediatrics 148(5): 465-467, 1989

Combined treatment with enuresis alarm and desmopressin for nocturnal enuresis. Acta Paediatrica 84(9): 1014-1018, 1995